I don't expect huge revenue or sales with this first product...

I don't expect huge revenue or sales with this first product release, but a steady start to income with plenty of upside for increased revenue as more products are released to market in the next 12 - 24 mths (especially the human health products). IMO this stock CPH will leave all other ASX Medical Cannabis stocks for dead in the next 2 years. Professional management and approach, Solid business plan covering many aspects of human and animal health globally. Patience required and good times to follow. This industry is growing rapidly and new highs will be found. Go CPH, go Creso and go Medical Cannabis.